Will Chinese Firms Take More Domestically Approved FIC Drugs To The World In 2026?

 
• By Dexter Jie Yan
  
perspectives 2026
2026 will probably see a limited number of Chinese firms advance their first-in-class drugs into the clinic overseas. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip Perspectives

More from Clinical Trials